Koers Invictus MD Strategies Corp Toronto S.E.
Aandelen
GENE
CA46183X2086
Farmaceutische producten
slotkoers
Andere beurzen
|
||
- CAD | - |
|
Omzet 2018 | 2,36 3,23 2,18 | Omzet 2019 | 4,69 6,4 4,32 | Marktkapitalisatie | 104 mln. 141 mln. 95,31 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2018 | -19 mln. -25,92 mln. -17,49 mln. | Nettowinst (verlies) 2019 | -35 mln. -47,74 mln. -32,23 mln. | EV/omzet 2018 | 45.833.024 x |
Nettoliquiditeiten 2018 | 37,59 mln. 51,28 mln. 34,61 mln. | Nettoschuld 2019 | 3,85 mln. 5,24 mln. 3,54 mln. | EV/omzet 2019 | 22.877.117 x |
K/w-verhouding 2018 |
-5,87
x | K/w-verhouding 2019 |
-2,45
x | Werknemers | - |
Dividendrendement 2018 * |
-
| Dividendrendement 2019 |
-
| Vrij verhandelbaar | 6,83% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Imran Haider
CEO | Chief Executive Officer | - | - |
Trevor Dixon
BRD | Director/Board Member | - | 09-05-19 |
Larry Heinzlmeir
IRO | Public Communications Contact | - | 24-01-17 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Trevor Dixon
BRD | Director/Board Member | - | 09-05-19 |
Jagdeep Gupta
BRD | Director/Board Member | - | 22-02-22 |
Greg Macdonald
BRD | Director/Board Member | - | 26-01-21 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+14,19% | 5,11 mld. | |
-33,68% | 3,43 mld. | |
-0,74% | 3,05 mld. | |
-24,38% | 2,59 mld. | |
-9,94% | 2,2 mld. | |
+39,98% | 1,86 mld. | |
+40,95% | 1,38 mld. | |
-14,41% | 1,37 mld. | |
+45,87% | 1,36 mld. |
- Beurs
- Aandelen
- Koers IVITF
- Koers GENE